Quarterly report pursuant to Section 13 or 15(d)

Premium Deficiency Reserve

v3.22.2.2
Premium Deficiency Reserve
9 Months Ended
Sep. 30, 2022
Premium Deficiency Reserve  
Premium Deficiency Reserve

Note 20: Premium Deficiency Reserve

The Company assesses the profitability of our at-risk share savings arrangements to identify contracts where current operating results or forecasts indicate probable future losses. If anticipated future variable costs exceed anticipated future revenues, a PDR is recognized. Management concluded a PDR of $27,719,928 and $37,835,642 existed at September 30, 2022 and December 31, 2021, respectively, which represented its estimate of probable contract losses expected to be generated by the Company’s contracts with its health plan partners.